LINC vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 21, 2026

LINC

47.9
AI Score
VS
LINC Wins

UTI

47.3
AI Score

Investment Advisor Scores

LINC

48score
Recommendation
HOLD

UTI

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LINC UTI Winner
Forward P/E 46.9484 33.3333 UTI
PEG Ratio 3.1333 2.2249 UTI
Revenue Growth 22.4% 7.2% LINC
Earnings Growth 20.0% -78.9% LINC
Tradestie Score 47.9/100 47.3/100 LINC
Profit Margin 4.0% 3.9% LINC
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LINC 1M: -37.6% · 3M: -45.1% UTI 1M: -42.2% · 3M: -38.9%

Current Technical Phase

LINC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.0%), weak momentum, RSI 20

RSI (14): 19.7 · Price: $25.72

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 26

RSI (14): 25.6 · Price: $22.35

Fundamentals Snapshot

Metric LINC UTI
Market Cap
Forward P/E 24.6 30.4
Trailing P/E 35.8 39.5
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.73 0.58
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LINC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.